Probiotec Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Probiotec Limited with three other
pharmaceutical manufacturers in Australasia:
AFT Pharmaceuticals Ltd
of NEW ZEALAND
(2020
sales of 105.60 million New Zealand Dollars [US$75.37 million]
of which 58%
was Australia),
Blis Technologies Ltd
of NEW ZEALAND
(10.64 million New Zealand Dollars [US$7.60 million]
), and
Vita Life Sciences Limited.
(46.48 million Australian Dollars [US$35.84 million]
).
Sales Analysis.
During the second
fiscal
quarter of 2021, sales at Probiotec Limited totalled
A$42.58 million.
This is a drop of 3.5%
from the A$44.11 million in sales at the company during the second quarter in 2020.
Probiotec Limited reported sales of A$107.22 million (US$82.67 million)
for the
fiscal
year ending
June of 2020.
This
represents
an
increase of 35.6%
versus 2019, when the company's sales were A$79.09 million.
This was the third consecutive year of growth at Probiotec Limited.